What researchers published on Áttétes emlőrák
30 315 papers, newest first.
Showing 160 of 30 315
Identifying Distant Breast Cancer Recurrence: A Proof-of-Concept Comparison of Discrete-Field Algorithm and Large Language Model Performance and Cost.JCO clinical cancer informatics
Single-cell multiomics profiling reveals tumour microenvironment landscape and sex-specific immune-suppressive feature in male breast cancer.Clinical and translational medicine
Comparison of five definitions of meaningful change on patient-reported outcomes in four SWOG clinical trials.Journal of patient-reported outcomes
ÁttekintésERα-Targeting PROTACs in Breast Cancer: Structural Design, Biological Mechanisms, Clinical Translation, and Implications for Multimodal Management.Critical reviews in oncology/hematology
Exploring women's perceptions of climate-related environmental stressors and their influence on palliative care experiences and quality of life among women with breast cancer in Ghana: a qualitative descriptive study.BMC palliative care
Dual-database pharmacovigilance analysis based on FAERS and JADER combined with network pharmacology to explore fulvestrant-associated respiratory toxicity.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Advanced Breast Cancer Patients Treated with Trastuzumab Deruxtecan: A Real-World Study.Journal of clinical medicine
MetaanalízisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
Real-World Implementation of Molecular Testing and Biomarker-Guided Therapies in HR+/HER2- Metastatic Breast Cancer.Cancers
Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE).Breast (Edinburgh, Scotland)
Early Magnetic Resonance Imaging and Single-Photon Emission Computerized Tomography Detection of Breast Cancer With Netrin-1-Specific Molecular and Liposome Probes.ChemMedChem
An EO771-Derived Metastatic Breast Cancer Model Exhibits RANKL-Associated Osteoimmune Remodeling Before Detectable Bone-Marrow Dissemination.Biology
ÁttekintésRechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors.Breast cancer research and treatment
Prognostic Value of Metabolic-Muscle Reserve Index in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.Journal of clinical medicine
Survival Differences Between De Novo and Recurrent HER2-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.Oncology
A Novel Function of Tubulin β2a and Tubulin β3 in Regulating Metastatic Properties in Bone-Metastatic Breast Cancer Cells.Cancers
ÁttekintésNavigating treatment for De novo oligometastatic breast cancer: The Assisi think tank meeting.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
KLRB1 (CD161) as a context-dependent prognostic marker in breast cancer: An exploratory analysis of CD4+ memory T cell infiltration: a retrospective multi-cohort study.Medicine
Addition of tucatinib to trastuzumab/pertuzumab after local therapy for isolated intracranial progression in HER2-positive metastatic breast cancer: primary results of the phase II BRIDGET trial.ESMO open
Pyramid-level training with stain normalization for breast cancer lymph-node metastasis segmentation in whole-slide images.PloS one
Phosphatidylserine modulation influences syncytia formation in human breast cancer cell lines.BMC cancer
EsetismertetésCase report: Fournier's gangrene occurring after inavolisib-induced hyperglycemia in a patient with metastatic breast cancer.Frontiers in pharmacology
Otological manifestations of disseminated metastatic breast cancer presenting with facial nerve palsy, tinnitus and otalgia.BMJ case reports
Metachronous gastric adenocarcinoma during sustained control of metastatic breast cancer.Revista espanola de enfermedades digestivas
ÁttekintésCellular/Molecular-assisted Early Detection of Breast Cancer: An Update.Anti-cancer agents in medicinal chemistry
CT-defined sarcopenia and outcomes in HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors.Frontiers in medicine
Cost-effectiveness of inavolisib plus palbociclib/fulvestrant versus palbociclib/fulvestrant for PIK3CA-mutated advanced breast cancer in China.Frontiers in pharmacology
Palbociclib, Fulvestrant, Trastuzumab, and Pyrotinib for Patients with Advanced Breast Cancer with Brain Metastases: A Prospective Multicenter Phase 2 Trial.Clinical cancer research : an official journal of the American Association for Cancer Research
Patterns of metastasis according to germline BRCA1/2 mutation status in patients with HER2-negative metastatic breast cancer.Breast cancer research : BCR
Ultra-sensitive MRD assessment in long-term complete responders to anti-HER2 therapy in HER2-positive metastatic breast cancer: initial results from HER2-CR study.ESMO open
Effect of different axillary management strategies on survival in elderly patients (≥70 Years) with early-stage breast cancer and 1-2 positive lymph nodes, stratified by risk factors.PloS one
High-Purity Magnetic Fluidic Isolation of Viable Circulating Tumor Cells Enables Single-Cell Multi-Omics Profiling.Analytical chemistry
Potential prognostic value of the free T3/T4 ratio in HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.BMC cancer
Interpreting EORTC CAT Core short-form scores in metastatic breast cancer: EQ-VAS-associated cut-points and comparison with published thresholds for clinical importance.Journal of patient-reported outcomes
Analytical and clinical validation of Ion Torrent™ Oncomine™ Dx Express Test for identifying PIK3CA/AKT1/PTEN-altered tumors in patients with hormone receptor-positive advanced breast cancer for treatment with capivasertib.Translational oncology
CD39-associated myeloid-T-cell coordination within an immunoregulatory neighborhood linked to treatment resistance in triple-negative breast cancer.Breast cancer research : BCR
Real-world outcomes of everolimus-based therapy after CDK4/6 inhibitor therapy in ER-positive/HER2-negative metastatic breast cancer: a multicenter registry-based study.Breast cancer (Tokyo, Japan)
EsetismertetésBreast metastasis from BRCA1-mutated ovarian cancer: response to parp inhibition and a potential lymphatic route.BMC women's health
Dual Primary Malignancies in Breast Cancer: Clinical Characteristics and Survival Predictors Among Hakka Women in Meizhou.Breast cancer (Dove Medical Press)
EsetismertetésSequential Anti-HER2 (Human Epidermal Growth Factor Receptor 2) Therapy and Late-Line Tucatinib in Patients With HER2-Positive Breast Cancer and Brain Metastases: A Real-World Case Report.Cureus
TP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers.Journal of molecular medicine (Berlin, Germany)
ÁttekintésMechanotransduction in breast cancer and implications for preclinical modeling.Cancer metastasis reviews
FOSL2 expression in histologically diagnosed breast cancer: first immunohistochemical evidence from Cameroon.BMC cancer
EsetismertetésExperience with pyrotinib monotherapy for advanced HER2-positive breast cancer with diffuse hepatic metastases and severe hepatic dysfunction: a case report.International journal of surgery case reports
ÁttekintésMitochondrial Calcium Signaling Acts in the Regulation of Quiescence in Estrogen Receptor-Positive Breast Cancer.The Yale journal of biology and medicine
Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer.Signal transduction and targeted therapy
MetaanalízisSequencing trastuzumab deruxtecan and sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis.European journal of clinical pharmacology
Molecular and clinical predictors of NAC response and relapse in HR+/HER2- early breast cancer.Breast cancer research : BCR
EsetismertetésSuccessful Trastuzumab Desensitization After a Severe Infusion-Related Reaction with Acute Hypoxemia and Suspected Pulmonary Toxicity in HER2-Positive Metastatic Breast Cancer: A Case Report.Cancer management and research
MetaanalízisPertuzumab in HER2-positive breast cancer: a systematic review and meta-analysis of randomized controlled trials.Breast cancer research and treatment
Chemoendocrine therapy versus tamoxifen with ovarian function suppression in women with node-positive breast cancer.Breast cancer research and treatment
ÁttekintésBrain Metastasis of Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.The breast journal
EsetismertetésOrganoid-Guided Precision Salvage Therapy for Advanced Breast Cancer with Multiple Metastases: A Case Report.International journal of women's health
Imlunestrant as Monotherapy or in Combination with Abemaciclib in ER+, HER2- Advanced Breast Cancer: Chinese Subgroup Analysis of the Phase III Randomized EMBER-3 Study.Targeted oncology
Real-world patient experiences in HR+/HER2- metastatic breast cancer: a study of symptom and side effect reporting by patients and physicians.Breast cancer research and treatment
Subtype conversion and metastatic timing in breast cancer liver metastasis.World journal of surgical oncology
Randomizált vizsgálatCardioprotective Effects of Low-Dose Bisoprolol Against Anthracycline-Induced Subclinical Cardiotoxicity in Breast Cancer: A Triple-Blind Randomized Controlled Trial Using Advanced Echocardiographic Parameters.Iranian journal of medical sciences
PreprintFORESEE: A prospective feasibility trial of functional precision oncology for metastatic breast cancer patients.medRxiv : the preprint server for health sciences
PreprintBreast Cancer Evaluation and Targeted Investigational Therapy (BEAT-IT): A Pilot Prospective Tissue-Testing Study for Breast Cancer Clinical Trial Enrollment.Research square
Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors.Cancer medicine
PreprintPhase II study of pembrolizumab plus nab-paclitaxel in Hormone Receptor-positive, HER2- negative metastatic breast cancer: clinical and molecular insights into response.Research square
Efficacy and Safety of Datopotamab Deruxtecan From a Single-Institution Experience in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer After Multiple Prior Therapies Including Antibody-Drug Conjugates.Cancer medicine
Development and internal validation of a nomogram for predicting short- and long-term overall survival in patients with breast cancer liver metastasis: a SEER-based prognostic study.Translational cancer research
Development of an algorithm to support cancer registry registration by identifying patients with metachronous metastases after primary breast cancer.ESMO real world data and digital oncology
ÁttekintésTwo Niches, One Disease: Brain and Leptomeningeal Metastases in Breast Cancer: A Narrative Review.Breast cancer (Dove Medical Press)
PreprintEvasion of Hepatic ILC1 Immunosurveillance Drives Breast Cancer Liver Metastasis.bioRxiv : the preprint server for biology
Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 - metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study.Breast cancer (Tokyo, Japan)
2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice-Commentary Based on a Virtual Focus Group.Clinical breast cancer
Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05.Future oncology (London, England)
Male breast cancer in Northern Tanzania: Clinicopathology and predictors of two-year survival (2016-2022).PloS one
Preclinical Evaluation of cRGD-Functionalized Lipid-Polymer Hybrid Nanocarriers for Anti-VEGF Gene Therapy in Triple-Negative Breast Cancer.Drug development research
Magnetic Resonance Imaging and Mammography Outcomes by Advanced Breast Cancer Risk.JAMA network open
Claudin-1 re-expression as a therapeutic strategy in Triple-negative breast cancer: transcriptional regulation.Molecular biology reports
PreprintTargeting MK2-Driven Stromal Senescence Sensitizes Breast Cancer Bone Metastasis to Immunotherapy.bioRxiv : the preprint server for biology
ÁttekintésImmune remodeling of breast tumor-draining lymph nodes: antigen-presenting cell dysfunction, regulatory T-cell expansion, and premetastatic niche formation.Frontiers in immunology
Treatment outcomes and quality of life with palbociclib in patients with advanced breast cancer who also have other medical conditions: a plain language summary of findings from POLARIS.Future oncology (London, England)
EsetismertetésAnti-trophoblast Cell-Surface Antigen 2 (TROP2)-Based Therapy for Concurrent Breast and Thyroid Malignancies.Cureus
EsetismertetésCase Report: Prolonged survival following multimodal treatment of leptomeningeal metastases in triple-negative glycogen-rich clear cell breast carcinoma.Frontiers in oncology
ÁttekintésHepatic surgery for breast cancer liver metastases in the modern systemic therapy era: narrative review of evidence, patient selection, and a multidisciplinary decision framework.Chinese clinical oncology
ÁttekintésBeyond Metastatic Lymphadenopathy in Breast Cancer: Approach to Axillary Masses.Radiographics : a review publication of the Radiological Society of North America, Inc
Circulating blood microbiome biomarkers as liquid biopsy in breast cancer.Journal of experimental & clinical cancer research : CR
Clinical impact of second radiotracer injection after failed lymphoscintigraphy in breast cancer sentinel lymph node biopsy: a retrospective cohort study.World journal of surgical oncology
Evolving First-Line Treatment Strategies in ERBB2-Positive Metastatic Breast Cancer: A Review.JAMA oncology
TFAP2A promotes the stemness and metastasis of luminal B/HER2-positive and triple-negative breast cancer cells by enhancing KDM4B transcriptional activity.Molecular biology reports
EsetismertetésAPOBEC3 Hypermutation Detection in Metastatic Breast Cancer via Targeted Next-Generation Sequencing.Journal of breast cancer
Reproducibility of 18F-FDG PET/CT-based tumour and nodal target delineation in stage II-III breast cancer.Radiation oncology (London, England)
Vizsgálati eredményEribulin mesylate in combination with ivonescimab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer(EMIT): study protocol for a single-arm, multicenter clinical trial.Frontiers in immunology
ÁttekintésLocoregional Approaches for Breast Cancer Liver Metastases: A Review.Journal of gastrointestinal cancer
Determinants of synchronous and metachronous metastatic breast cancer (2000-2024)-an analysis based on data from German cancer registries.Journal of cancer research and clinical oncology
Esetismertetés[Sustained disease control with sacituzumab govitecan in a patient with HR+/HER2- metastatic breast cancer resistant to endocrine therapy, with a high tumour burden and limited benefit from standard chemotherapy.].Recenti progressi in medicina
Body composition at diagnosis: a key determinant of tumor metabolism and cardiometabolic health in breast cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Verification of a previously obtained EQA based MUC1/CA15-3 harmonisation procedure.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
EsetismertetésA rare neurological adverse event of palbociclib: a chronic inflammatory demyelinating polyneuropathy (CIDP) mimic.Breast cancer research and treatment
Esetismertetés[Efficacy of sacituzumab govitecan following treatment with trastuzumab deruxtecan in a patient with HR-positive/HER2-low metastatic breast cancer.].Recenti progressi in medicina
Esetismertetés[CDK4/6 inhibitor to antibody-drug conjugates in HER2-low metastatic breast cancer: sequential therapeutic management of a case report.].Recenti progressi in medicina
Clinical significance of extranodal extension in mastectomy patients with limited sentinel lymph node macrometastases: a retrospective cohort study.World journal of surgical oncology
EsetismertetésRefractory Hypocalcemia Induced by Denosumab and Nab-Paclitaxel in a Patient With Metastatic Breast Cancer.AACE endocrinology and diabetes
Esetismertetés[Cervical lymph node metastasis as the initial presentation of poorly differentiated esophageal carcinoma mimicking breast origin: a diagnostic challenge].Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
Novel therapies create potential new options for patients with advanced breast cancer: First-line sacituzumab govitecan plus pembrolizumab may improve long-term outcomes for patients with advanced triple-negative breast cancer, whereas the new CDK4/6 inhibitor fovinaciclib shows promising efficacy.Cancer
ÁttekintésSafety-guided selection of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer: toxicity profiles, dose modification, and clinical risk-benefit considerations.Therapeutic advances in drug safety
ÁttekintésEfficacy and safety of palbociclib in older women with advanced HR-Positive/HER2-negative breast cancer: a systematic review and meta-analysis.Expert opinion on pharmacotherapy
Camizestrant (Etcamah®): an oral estrogen receptor degrader and estrogen receptor antagonist approved for breast cancer.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Identification of YL064 as a novel inhibitor of ATXN3 to suppress tumor growth and metastasis by promoting degradation of oncogenic substrates.Cell death & disease
Circulating FABP4 promotes obesity-associated breast cancer lung metastasis through PIP2.Cell reports
Venous thromboembolism after breast cancer surgery: incidence, predictive factors and outcomes in 270,564 patients.Breast cancer research and treatment
Nanocatalytic Immunotherapy Targeting Tumor-Resident Intracellular Bacteria for Triple-Negative Breast Cancer Treatment and Metastasis Suppression.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Single-Cell Characterization of SPP1-Expressing Macrophages and Their Predicted Interactions With T Cells in the Breast Cancer Bone Metastatic Microenvironment.Cancer reports (Hoboken, N.J.)
Non-invasive electromagnetic fields induce anti-tumor neutrophil reprogramming and enhance checkpoint blockade in breast cancer.Frontiers in immunology
Managing trastuzumab deruxtecan-related adverse events in patients with metastatic breast cancer: insights from a worldwide survey of the Hermione EDUcational project.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Study design of the phase III ADELA trial of elacestrant with or without everolimus in ESR1-mutated ER+/HER2- advanced breast cancer after progression on endocrine therapy plus a CDK4/6 inhibitor.Future oncology (London, England)
EsetismertetésMetastatic ductal carcinoma concealed within poorly differentiated thyroid carcinoma: Case report and literature review.Indian journal of pathology & microbiology
Patient frustration with time spent on advanced ovarian and metastatic breast cancer care.Gynecologic oncology reports
MetaanalízisPrognosis and therapeutic choices for occult breast cancer in female patients: a systematic review and meta-analysis.BMC surgery
Assessment of Metastatic Dissemination in Mouse Breast Carcinoma Models Using Magnetic Resonance Imaging (MRI).Methods in molecular biology (Clifton, N.J.)
MCOLN2 (Mucolipin-2) promotes autophagy to confer Adriamycin resistance in breast cancer by regulating mTOR degradation.Cellular oncology (Dordrecht, Netherlands)
ÁttekintésDrugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer.European journal of cancer (Oxford, England : 1990)
Real-world comparative outcomes of pyrotinib-based versus pertuzumab-based first-line therapy in HER2-Positive advanced breast cancer: a multicenter retrospective cohort study from Xinjiang, China.Frontiers in pharmacology
Real-world efficacy and safety of trastuzumab emtansine biosimilar (UJVIRA®) in early and metastatic HER2-positive breast cancer: a multicenter pooled retrospective analysis from India.Breast cancer research and treatment
Randomizált vizsgálatReal-Time Electronic Patient-Reported Outcome Monitoring With Digital Triage and Care-Team Integration in Early Breast Cancer: ENABLE Randomized Controlled Trial.Journal of medical Internet research
ÁttekintésThe Current Landscape of Exosome-Based Strategies for Breast Cancer Brain Metastasis: From Mechanistic Insights to Therapeutic Potential.International journal of nanomedicine
Szisztematikus áttekintésTumor lysis syndrome in breast cancer: a systematic review of the literature.Frontiers in oncology
Economic evaluation of pertuzumab in early versus late settings of HER2-positive breast cancer: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care
Megfigyeléses vizsgálatClinicopathological features, prognostic factors and treatment outcome in male breast cancer: An observational retrospective study from tertiary cancer center.Journal of cancer research and therapeutics
Sociodemographic and clinicopathologic features associated with rapid relapse in triple-negative breast cancer: a Swedish nationwide registry-based study.Breast cancer research and treatment
Biomimetic M1 macrophage Membrane-Modified liposomes Co-delivering ponatinib and ginsenoside Rg3 for inhibition of breast cancer lung metastasis.Journal of ginseng research
ÁttekintésPost CDK4/6 inhibitors: Novel targeted combinations based on SERDs in HR+/HER2- advanced breast cancer.Acta pharmaceutica Sinica. B
To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission.Breast (Edinburgh, Scotland)
Efficacy and safety of sacituzumab govitecan in metastatic breast cancer: a single-center retrospective cohort study.Frontiers in oncology
An Inverse-Selection-Probability Weighted Approach for Real-World Progression-Free Survival With Left-Truncated Clinico-Genomic Data.Pharmaceutical statistics
Predictive Value of Combined Ultrasound Viscoelasticity Imaging, CEUS, AAPR, and PLR for Assessing Neoadjuvant Chemotherapy Efficacy in Breast Cancer.Breast cancer (Dove Medical Press)
Turn Shield into Sword: Pathological Hydroxyapatite-Targeting Micelles Drive Metabolic Stress-Induced Autophagy Dysfunction for Bone Metastasis Therapy.ACS nano
ÁttekintésCapivasertib Combination Therapy in Advanced Breast Cancer and Other Solid Tumors: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Biomarker-Defined Outcomes.Pharmaceuticals (Basel, Switzerland)
Disparities in screening participation and stage at diagnosis for breast and bowel cancers among individuals with pre-existing mental health disorders: A population-based study.PloS one
Pretreatment Body Composition and Its Association with Pathologic Complete Response and Survival in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Retrospective Cohort Study.Medicina (Kaunas, Lithuania)
ÁttekintésAssociations and Similarities Between Breast Cancer and Vulvar Cancer: A Comprehensive Literature Review.Medicina (Kaunas, Lithuania)
Resistance to membrane damage enhances metastatic potential of breast cancer cells via dysregulated phospholipid profiles and annexin-mediated repair.Cellular and molecular life sciences : CMLS
Association of Baseline Serum DKK-1 Levels with Subsequent Bone Metastasis in Stage III Breast Cancer.Medicina (Kaunas, Lithuania)
ARMCX3 Regulates Breast Cancer Progression and Cisplatin Responsiveness Through p53-Related Signaling.Biology
The Role of Long Non-Coding RNAs and MicroRNAs in Breast Cancer: Implications for Early Diagnosis, Prognosis, and Axillary Lymph Node Metastasis.Asian Pacific journal of cancer prevention : APJCP
ÁttekintésEndoplasmic reticulum stress in breast cancer metastasis: mechanisms and therapeutic implications.The Journal of pharmacy and pharmacology
Serum Proteomic Profiling by SomaScan Aptamer Array Identifies Candidate Predictive and Monitoring Biomarkers of Distant Recurrence in Triple-Negative Breast Cancer.International journal of molecular sciences
ZEB1 Defines the Interaction Between Breast Cancer Cells and Macrophages by Upregulating the Expression of CCL2 Cytokine.International journal of molecular sciences
Baseline Serum Albumin Is Associated With Severe Adverse Events During Trastuzumab Deruxtecan Treatment in Metastatic Breast Cancer.Anticancer research
Biologic and morphologic determinants of post-neoadjuvant ultrasound detectability of clipped axillary lymph nodes in targeted axillary dissection.World journal of surgical oncology
Receptor Status Changes, HER2-Low Discordance, and TNBC Transformation in Metastatic Breast Cancer: Prognostic Significance and Impact on Survival Outcomes.Journal of clinical medicine
NDUFS1 promotes malignant breast cancer behaviors through enhancement of mitochondrial respiration and PROX1/c-Myc signaling.iScience
Societal and Healthcare Costs of Post-IDFS Events Following Adjuvant Ribociclib Plus an Aromatase Inhibitor (AI) Versus AI Alone in Pre- and Postmenopausal Women with Early HR+/HER2- Breast Cancer in Canada.Current oncology (Toronto, Ont.)
Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer.The New England journal of medicine
Does the Number of Harvested Sentinel Lymph Nodes Matter in Breast Cancer Patients with Limited Nodal Burden? A Descriptive Cohort Study.Medical sciences (Basel, Switzerland)
Circulating tumor DNA in breast cancer in 2027: advancing liquid biopsy and molecular monitoring.Current opinion in obstetrics & gynecology
Association Between the Number of Invasive Tumor Foci and Axillary Nodal Burden in Multifocal and Multicentric Breast Cancer.Current oncology (Toronto, Ont.)
Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.Current oncology (Toronto, Ont.)
Circulating tumor cells in lobular versus ductal metastatic breast cancer.Breast cancer research and treatment
The Impact of the Antidiabetic Agent Sitagliptin on the Radiation Response of Breast Carcinoma Cells with Different Metastatic Capacities.Cells
Cardiotoxicity of Immune Checkpoint Inhibitors with Anthracycline Chemotherapy in Triple-Negative Breast Cancer.Current oncology (Toronto, Ont.)
From cN2 to ypN0: Nodal Downstaging After Neoadjuvant Treatment in Breast Cancer-A Retrospective Cohort Study from a Tertiary Cancer Center.Medical sciences (Basel, Switzerland)
Efficacy and toxicity for pembrolizumab-containing therapy in older adults with triple-negative breast cancer: insights from routine oncology practice.Breast cancer research and treatment
ÁttekintésA HALF CENTURY OF PROGRESS IN BREAST CANCER: WHERE DO WE GO NEXT?Transactions of the American Clinical and Climatological Association
[Predictive value of dynamic contrast-enhanced magnetic resonance imaging features for the efficacy of neoadjuvant chemotherapy in breast cancer patients with non-mass enhancement].Zhonghua zhong liu za zhi [Chinese journal of oncology]
CDK4/6 Inhibitors in the Treatment of Advanced ER/PR-Positive, HER2-Negative Breast Cancer: An Updated Single-Center Analysis of Real-World Data.Breast care (Basel, Switzerland)